Skip to content

Clinical trials

Phase 3 Peripheral Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Nervous System Diseases Phase: Phase 3 Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20055
20063
20074
20081
20092
20101
20112
20131
20141
20154
20162
20171
20192
20201
20211
20235
20241
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Unknown status11
Terminated5
Recruiting4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NeurogesX6
Apurano Pharmaceuticals GmbH4
Jazz Pharmaceuticals4
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.4
Laboratoire français de Fractionnement et de Biotechnologies2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Pharnext S.C.A.2
Alliance for Clinical Trials in Oncology1
Ankara Education and Research Hospital1
Aya Mohamed Sadek Elsaid1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Nervous System Diseases49
Pain23
Diabetic Neuropathies10
Neuralgia8
Diabetes Mellitus7
Chronic Pain5
HIV Infections5
Polyneuropathies5
Agnosia4
Marijuana Abuse4

Trials

Showing 51 to 49 of 49. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.